FI
FibroGen Inc
🇺🇸XNAS.FGENUnited StatesHealthcare
$9.71USDup +0.48 (+5.2%)OpenDelayed5:39 PM
Price$9.71+0.48 (+5.2%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US31572Q8087
- CUSIP
- 31572Q808
Company
- Employees
- 225
- Headquarters
- San Francisco, United States
- Website
- https://www.fibrogen.com
- CEO
- Mr. Thane Wettig
Market
- Shares outstanding
- 4M
- Market cap
- $39.28M
Highlights
- Market cap
- $39.28M
- EPS LTM
- $53.31calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- 0.18calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- 12.59%
Fundamentals (LTM)
- Revenue
- -$118.09M-218.29%down year on year
- Net income
- $215.65M+277.07%up year on year
- Gross margin
- 82.74%+6,977.46%up year on year
- Free cash flow
- -$17.09M+86.46%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.